Novartis
NVS
#56
Rank
NZ$351.85 B
Marketcap
$175.93
Share price
0.39%
Change (1 day)
11.56%
Change (1 year)

Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.

Earnings for Novartis (NVS)

Earnings in 2024 (TTM): NZ$20.63 Billion

According to Novartis's latest financial reports the company's current earnings are NZ$49.94 Billion. In 2023 the company made an earning of NZ$15.50 Billion, an increase over its 2022 earnings that were of NZ$13.66 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novartis from 2000 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$20.63 B33.08%
2023 NZ$15.50 B13.48%
2022 NZ$13.66 B-69.24%
2021 NZ$44.43 B164.6%
2020 NZ$16.79 B10.49%
2019 NZ$15.19 B-36.26%
2018 NZ$23.84 B55.86%
2017 NZ$15.29 B15.12%
2016 NZ$13.28 B-3.9%
2015 NZ$13.82 B-33.72%
2014 NZ$20.86 B14.87%
2013 NZ$18.16 B-2.93%
2012 NZ$18.70 B2.15%
2011 NZ$18.31 B-7.94%
2010 NZ$19.89 B17.94%
2009 NZ$16.86 B4.45%
2008 NZ$16.14 B27.5%
2007 NZ$12.66 B-6.31%
2006 NZ$13.51 B9.46%
2005 NZ$12.35 B5.17%
2004 NZ$11.74 B13.84%
2003 NZ$10.31 B-38.51%
2002 NZ$16.77 B574.04%
2001 NZ$2.48 B83%
2000 NZ$1.36 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$28.03 B 29.52%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$2.07 Billion-109.52%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$31.27 B 44.48%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$12.59 B-41.82%๐Ÿ‡ซ๐Ÿ‡ท France
NZ$7.09 B-67.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$1.40 B-93.50%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
-NZ$11.7 Billion-154.04%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$11.52 B-46.76%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$15.98 B-26.15%๐Ÿ‡ฌ๐Ÿ‡ง UK